2C-T-15
| Clinical data | |
|---|---|
| Other names | 4-Cyclopropylthio-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-cyclopropylthiophenethylamine; Sesqui; SESQUI |
| Routes of administration | Oral[1] |
| Drug class | Psychoactive drug |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | "Several hours"[1] |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19NO2S |
| Molar mass | 253.36 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 203.5 to 204.5 °C (398.3 to 400.1 °F) |
| |
| |
| NY (what is this?) (verify) | |
2C-T-15, also known as 4-cyclopropylthio-2,5-dimethoxyphenethylamine or as Sesqui, is a psychoactive drug of the phenethylamine and 2C families.[1]
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists 2C-T-15's dose as greater than 30 mg orally and its duration as "several hours".[1] The drug produced threshold effects and possible talkativeness at doses of 6 to 30 mg orally, but there were no other effects nor clear hallucinogenic effects.[1] Higher doses were not tested.[1]
Interactions
Chemistry
2C-T-15 is the 2 carbon homologue of Aleph-15, which has not been synthesized.[1] The full chemical name is 2-[4-(2-cyclopropylthio)-2,5-dimethoxyphenyl]ethanamine.[1] The drug has structural properties similar to 2C-T-2 and other drugs in the 2C-T series.[1]
Synthesis
The chemical synthesis of 2C-T-15 has been described.[1]
History
2C-T-15 was first described in the scientific literature by Alexander Shulgin and colleagues in 1991.[2] Subsequently, it was described in greater detail in his book PiHKAL (Phenethylamines I Have Known and Loved) that same year.[1]
Society and culture
Legal status
Canada
As of October 31, 2016, 2C-T-15 is a controlled substance (Schedule III) in Canada.[3]
United Kingdom
2C-T-15 is a class A drug in the UK under the Misuse of Drugs act.
United States
2C-T-15 is not explicitly illegal in the USA, but possession and sales of 2C-T-15 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
See also
References
- ^ a b c d e f g h i j k Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal047.shtml
- ^ Shulgin AT, Shulgin A, Jacob P (January 1991). "Central nervous system (CNS) activity of two new psychoactive compounds". Journal of Psychoactive Drugs. 23 (1): 95–96. doi:10.1080/02791072.1991.10472583. eISSN 2159-9777. PMID 1941371. Archived from the original on 2025-07-13.
- ^ "Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". 4 May 2016.
External links
| Phenethylamines |
| ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Amphetamines |
| ||||||||||||||||
| Phentermines |
| ||||||||||||||||
| Cathinones |
| ||||||||||||||||
| Phenylisobutylamines (and further-extended) | |||||||||||||||||
| Catecholamines (and close relatives) |
| ||||||||||||||||
| Cyclized phenethylamines |
| ||||||||||||||||
| Related compounds |
| ||||||||||||||||
| |||||||||||||||||